An interventional study of Vestal Device and Control Device in Overweight, Obesity and Overweight and Obesity, sponsored by Neurovalens Ltd.. Completed at 1 site in Ireland. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-04-03.
Sponsored by Neurovalens Ltd. · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 41 studies in Obesity with a site in Ireland — 9 open to participants now, 10 under way, none of them phase 3. Obesity · Ireland.
Among the 41 studies in Obesity with a site in Ireland, this one is the 27th largest by enrollment of the 32 interventional ones that give a count, is one of 2 that started in 2020, is one of 18 with no phase, and was the 22nd registered.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
Browse Obesity studies →9 of the 41 studies in Obesity with a site in Ireland are open now. Recruiting first, the newest first:
University College Dublin · Sites in Ireland
Ages 16–80
The Cleveland Clinic · Sites in Ireland, United States, Brazil and 10 more countries
Ages 18–75 · Healthy volunteers
University College Cork · Sites in Ireland
Ages 50–65 · Healthy volunteers
University College Dublin · Sites in Ireland
Ages 18–65
University College Dublin · Sites in Ireland
Ages 18+
A study can be open while its sites in Ireland have not opened yet or have stopped. Only those recruiting at a site in Ireland →
Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
41 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 3 · Phase 3 9 · Phase 4 3
First in 2005; this study’s year is marked. 2 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 50 is below the median of 67 across 9,043 interventional studies indexed under Obesity.
Median enrollment 126 across the 32 interventional studies, 317 across the 9 observational. Of the 25 that completed or were terminated, 7 (28%) have results posted.
This tab as a report to print or save as PDF → With an account.
14 of 41 have an industry lead sponsor. The 10 most frequent:
Neurovalens Ltd. is the lead sponsor of 20 studies on the registry; 1 is open to participants now.
Neurovalens Ltd. has 5 studies filed under Obesity — fewer than ten, so there is no comparison to draw.
2 of the studies in Obesity with a site in Ireland that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04174755University College DublinSemaglutide's Efficacy in Achieving Weight Loss for Those With HIV | 2027-01 |
| NCT04432025Imperial College LondonMedication Following Bariatric Surgery for Type 2 Diabetes Mellitus | 2027-04-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 41 studies in Obesity with a site in Ireland, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
A randomized, double blind sham controlled clinical trial to evaluate the efficacy of vestibular nerve stimulation (VeNS), together with a lifestyle modification program, compared to a sham control with a lifestyle modification programme, as a means of reducing excess body weight and body fat.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
This study's enrollment of 50 is below the median of 67 across 9,043 interventional studies indexed under Obesity.
Browse Obesity studies →Neurovalens Ltd. is the lead sponsor of 20 studies on the registry; 1 is open to participants now.
Compared within Obesity, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Overweight. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
(BMI) ≥ 25 kg/m2 2. Males or Females. Note females of must have a negative urine pregnancy test They should agree to follow a physician-approved regimen for the duration of the study period (other than DMPA injections as this causes weight gain).
Exclusion Criteria:
History of vestibular dysfunction or other inner ear disease as indicated by the screening questions.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Childbearing potential
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
25 subjects randomised to receive active device use plus lifestyle intervention for 3 months.
Device: Vestal Device · Behavioral: Hypocaloric Diet
25 subjects randomised to receive control device use plus lifestyle intervention for 3 months.
Device: Control Device · Behavioral: Hypocaloric Diet
Vestibular nerve stimulator
Control Device
Hypocaloric diet
Total body weight loss
In kg
Time frame: 12 weeks
Plan to share: No
No publications or documents are linked to this record.
Ran from Oct 2020 to primary completion in Mar 2021, 5 months.
Of 164 industry-sponsored interventional studies with no phase under Obesity, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 27. This study's 5 months is below that.
Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.